Jeffrey Poulton V.

Insider Reports History

Location
Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Poulton V.:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Common Stock 61,805 $20,128,034 $325.67 04 Mar 2026 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Restricted Stock Units 0 $465,762 $244.11 27 Feb 2026 Direct
Homology Medicines, Inc. Director Option (Right to Buy) 23,000 $308,660 $13.42 14 Jun 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Common Stock 57 $18,369 $322.28 04 Mar 2026 by Managed Account
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Stock Option (right to buy) 10,480 02 Mar 2026 Direct
CervoMed Inc. Director Stock Option (Right to Buy) 8,100 23 Jun 2025 Direct

Insider Reports Filed by Jeffrey Poulton V.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 04 Mar 2026 8 -$797,351 4 EVP, Chief Financial Officer 06 Mar 2026, 16:12
ALNY ALNYLAM PHARMACEUTICALS, INC. 02 Mar 2026 12 -$722,801 4 EVP, Chief Financial Officer 04 Mar 2026, 19:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2026 2 $0 4 EVP, Chief Financial Officer 02 Mar 2026, 16:09
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Feb 2026 2 -$695,201 4 EVP, Chief Financial Officer 17 Feb 2026, 19:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 11 Jan 2026 22 -$1,008,766 4 EVP, Chief Financial Officer 14 Jan 2026, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Oct 2025 14 -$1,727,284 4 EVP, Chief Financial Officer 03 Oct 2025, 17:14
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Aug 2025 9 -$1,030,727 4 EVP, Chief Financial Officer 19 Aug 2025, 17:27
CRVO CervoMed Inc. 23 Jun 2025 1 $0 4 Director 25 Jun 2025, 17:01
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2025 9 -$308,141 4 EVP, Chief Financial Officer 05 Mar 2025, 16:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2025 10 -$192,390 4 EVP, Chief Financial Officer 03 Mar 2025, 16:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 13 Feb 2025 13 -$246,750 4 EVP, Chief Financial Officer 18 Feb 2025, 16:47
ALNY ALNYLAM PHARMACEUTICALS, INC. 25 Nov 2024 6 -$422,144 4 EVP, Chief Financial Officer 27 Nov 2024, 17:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 24 Jun 2024 13 -$370,747 4 EVP, Chief Financial Officer 26 Jun 2024, 16:26
CRVO CervoMed Inc. 14 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Mar 2024 2 $0 4 EVP, Chief Financial Officer 05 Mar 2024, 16:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2024 7 -$89,145 4 EVP, Chief Financial Officer 29 Feb 2024, 16:18
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Feb 2024 4 -$149,099 4 EVP, Chief Financial Officer 20 Feb 2024, 16:08
CRVO CervoMed Inc. 15 Sep 2023 1 $0 4 Director 15 Sep 2023, 18:52
CRVO CervoMed Inc. 16 Aug 2023 0 $0 3 Director 23 Aug 2023, 21:48
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2023 8 -$643,037 4 EVP, Chief Financial Officer 07 Aug 2023, 18:05
QTTB Homology Medicines, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:09
ALNY ALNYLAM PHARMACEUTICALS, INC. 26 Apr 2023 6 -$190,113 4 EVP, Chief Financial Officer 28 Apr 2023, 17:55
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2023 2 $0 4 EVP, Chief Financial Officer 01 Mar 2023, 15:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2022 7 -$968,824 4 EVP, Chief Financial Officer 05 Aug 2022, 16:14
QTTB Homology Medicines, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:05
ALNY ALNYLAM PHARMACEUTICALS, INC. 23 Feb 2022 1 $0 4 EVP, Chief Financial Officer 25 Feb 2022, 15:12
QTTB Homology Medicines, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 17:39